共有 50 笔近期内部人交易记录记录，涉及 Sensei Biotherapeutics, Inc. (SNSE), 包括 30 笔买入 和 14 笔卖出. 内部人买入总额为 $34.69M 内部人卖出总额为 $4.14M.
近期活跃的重要内部人包括 Parikh Anand Kiran, Donenberg Phillip B., Cambrian Biopharma Inc. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — SNSE
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-02-19 |
Parikh Anand Kiran |
Chief Operating Officer |
限制性股票授予 (RSU) |
1,239,305 |
$27.22 |
$33.73M |
1,239,305 |
| 2026-02-17 |
Parikh Anand Kiran |
Officer |
未知 |
- |
- |
- |
- |
| 2026-02-17 |
Parikh Anand Kiran |
Chief Operating Officer |
限制性股票授予 (RSU) |
56,673 |
$1.16 |
$65.74K |
56,673 |
| 2026-02-13 |
Donenberg Phillip B. |
Officer |
未知 |
- |
- |
- |
- |
| 2026-02-13 |
Donenberg Phillip B. |
Director |
限制性股票授予 (RSU) |
1,900 |
$9.09 |
$17.27K |
1,900 |
| 2025-12-09 |
Cambrian Biopharma Inc |
10 Percent Owner |
期权行权（卖出） |
395 |
$6.40 |
$2.53K |
- |
| 2025-12-09 |
Peyer James |
10 Percent Owner, Other: See Remarks Below |
期权行权（卖出） |
395 |
$6.40 |
$2.53K |
- |
| 2025-12-08 |
Peyer James |
10 Percent Owner, Other: See Remarks Below |
知情卖出 |
3,105 |
$8.59 |
$26.67K |
158,254 |
| 2025-12-05 |
Cambrian Biopharma Inc |
10 Percent Owner |
知情卖出 |
42 |
$13.16 |
$552.72 |
161,359 |
| 2025-12-05 |
Peyer James |
10 Percent Owner, Other: See Remarks Below |
知情卖出 |
42 |
$13.16 |
$552.72 |
161,359 |
| 2025-12-04 |
Cambrian Biopharma Inc |
10 Percent Owner |
知情卖出 |
5,000 |
$9.06 |
$45.3K |
177,654 |
| 2025-12-04 |
Peyer James |
10 Percent Owner, Other: See Remarks Below |
知情卖出 |
5,000 |
$9.06 |
$45.3K |
177,654 |
| 2025-11-14 |
Gerry Christopher |
President & Peo |
未知 |
5,881 |
$15.70 |
$92.34K |
- |
| 2025-05-21 |
Ricks Thomas G |
Director |
限制性股票授予 (RSU) |
19,000 |
$0.32 |
$6.08K |
19,000 |
| 2025-05-21 |
Ringo William R |
Director |
限制性股票授予 (RSU) |
19,000 |
$0.32 |
$6.08K |
19,000 |
| 2025-05-21 |
Cambrian Biopharma Inc |
10 Percent Owner |
限制性股票授予 (RSU) |
19,000 |
$0.32 |
$6.08K |
19,000 |
| 2025-05-21 |
Holmen Bob |
Director |
限制性股票授予 (RSU) |
19,000 |
$0.32 |
$6.08K |
19,000 |
| 2025-05-21 |
Peyer James |
10 Percent Owner |
限制性股票授予 (RSU) |
19,000 |
$0.32 |
$6.08K |
19,000 |
| 2025-05-21 |
Humer Kristian |
Director |
限制性股票授予 (RSU) |
19,000 |
$0.32 |
$6.08K |
19,000 |
| 2025-02-19 |
Celebi John |
President and CEO |
RSU 预扣税 |
5,558 |
$0.48 |
$2.65K |
105,862 |
| 2025-02-19 |
Van Der Horst Edward |
Chief Scientific Officer |
RSU 预扣税 |
2,276 |
$0.48 |
$1.08K |
59,794 |
| 2025-02-14 |
Celebi John |
President and CEO |
限制性股票授予 (RSU) |
360,000 |
$0.48 |
$171.36K |
360,000 |
| 2025-02-14 |
Van Der Horst Edward |
Chief Scientific Officer |
限制性股票授予 (RSU) |
110,000 |
$0.48 |
$52.36K |
110,000 |
| 2025-02-14 |
Krebs Stephanie |
Chief Business Officer |
限制性股票授予 (RSU) |
120,000 |
$0.48 |
$57.12K |
120,000 |
| 2025-02-14 |
Craver Josiah |
Principal Financial Officer |
限制性股票授予 (RSU) |
50,000 |
$0.48 |
$23.8K |
50,000 |
| 2024-12-20 |
Celebi John |
President and CEO |
限制性股票授予 (RSU) |
355,000 |
$0.45 |
$159.71K |
355,000 |
| 2024-12-20 |
Van Der Horst Edward |
Chief Scientific Officer |
限制性股票授予 (RSU) |
100,000 |
$0.45 |
$44.99K |
100,000 |
| 2024-12-20 |
Krebs Stephanie |
Chief Business Officer |
限制性股票授予 (RSU) |
120,000 |
$0.45 |
$53.99K |
120,000 |
| 2024-12-20 |
Craver Josiah |
Principal Financial Officer |
限制性股票授予 (RSU) |
100,000 |
$0.45 |
$44.99K |
100,000 |
| 2024-09-17 |
Craver Josiah |
Principal Financial Officer |
未知 |
80,000 |
$0.66 |
$52.8K |
- |
| 2024-06-11 |
Ricks Thomas G |
Director |
限制性股票授予 (RSU) |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
Ringo William R |
Director |
限制性股票授予 (RSU) |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
Cambrian Biopharma Inc |
10 Percent Owner |
限制性股票授予 (RSU) |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
Holmen Bob |
Director |
限制性股票授予 (RSU) |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
Vojta Deneen |
Director |
限制性股票授予 (RSU) |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
Peyer James |
10 Percent Owner |
限制性股票授予 (RSU) |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
English Jessie |
Director |
限制性股票授予 (RSU) |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-06-11 |
Humer Kristian |
Director |
限制性股票授予 (RSU) |
19,000 |
$0.71 |
$13.47K |
19,000 |
| 2024-05-10 |
Gaiero David G |
Officer |
未知 |
- |
- |
- |
- |
| 2024-02-15 |
Celebi John |
President and CEO |
RSU 预扣税 |
5,891 |
$0.79 |
$4.65K |
105,420 |
| 2024-02-15 |
Colgan Erin |
Chief Financial Officer |
RSU 预扣税 |
3,627 |
$0.79 |
$2.87K |
67,462 |
| 2024-02-15 |
Van Der Horst Edward |
Chief Scientific Officer |
RSU 预扣税 |
2,843 |
$0.79 |
$2.25K |
56,070 |
| 2023-11-01 |
Krebs Stephanie |
Officer |
未知 |
- |
- |
- |
- |
| 2023-11-01 |
Krebs Stephanie |
Chief Business Officer |
限制性股票授予 (RSU) |
125,000 |
$0.82 |
$102.5K |
125,000 |
| 2023-09-11 |
Celebi John |
President and CEO |
知情买入 |
500 |
$0.85 |
$425.00 |
111,311 |
| 2023-07-31 |
Cambrian Biopharma Inc |
10 Percent Owner |
股份退回 |
1,587,302 |
$1.26 |
$2M |
3,653,120 |
| 2023-07-31 |
Peyer James |
10 Percent Owner |
股份退回 |
1,587,302 |
$1.26 |
$2M |
3,653,120 |
| 2023-07-10 |
Ricks Thomas G |
Director |
限制性股票授予 (RSU) |
4,466 |
- |
- |
8,932 |
| 2023-07-10 |
Ringo William R |
Director |
限制性股票授予 (RSU) |
14,550 |
$1.22 |
$17.75K |
14,550 |
| 2023-07-10 |
Broder Samuel |
Director |
限制性股票授予 (RSU) |
4,466 |
- |
- |
8,932 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
